Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Nouveau Monde Graphite plans to raise capital via stock (SeekingAlpha) +++ NOUVEAU MONDE Aktie -4,89%

ACURX Aktie

>ACURX Performance
1 Woche: 0%
1 Monat: 0%
3 Monate: +17,2%
6 Monate: 0%
1 Jahr: 0%
laufendes Jahr: 0%
>ACURX Aktie
Name:  ACURX PHARMACEUTICALS
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US00510M2035 / A41DXH
Symbol/ Ticker:  3ZO0 (Frankfurt) / ACXP (NASDAQ)
Kürzel:  FRA:3ZO0, ETR:3ZO0, 3ZO0:GR, NASDAQ:ACXP
Index:  -
Webseite:  https://www.acurxpharma.c..
Profil:  Acurx Pharmaceuticals, Inc. is a late-stage biopha..
>Volltext..
Marktkapitalisierung:  6.38 Mio. EUR
Unternehmenswert:  1.35 Mio. EUR
Umsatz:  -
EBITDA:  -7.87 Mio. EUR
Nettogewinn:  -7.82 Mio. EUR
Gewinn je Aktie:  -7.27 EUR
Schulden:  -
Liquide Mittel:  5.03 Mio. EUR
Operativer Cashflow:  -6.69 Mio. EUR
Bargeldquote:  2.39
Umsatzwachstum:  -
Gewinnwachstum:  44.21%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  ACURX
Letzte Datenerhebung:  18.12.25
>ACURX Kennzahlen
Aktien/ Unternehmen:
Aktien: 2.09 Mio. St.
Frei handelbar: 91.89%
Rückkaufquote: -106.84%
Mitarbeiter: 4
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Strong buy
Kursziel: 652.09%
Bewertung:
KGV: -
KGV lG: -
KUV: -
KBV: 1.78
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -
Gewinnmarge: -
Operative Marge: -
Managementeffizenz:
Gesamtkaprendite: -151.72%
Eigenkaprendite: -291.07%
>ACURX Peer Group

Es sind 599 Aktien bekannt.
 
15.11.25 - 18:18
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television (Accesswire)
 
Featured companies include Lionscrest Advisors, DataVault AI (NASDAQ:DVLT), Pudgy Penguins (PENGU)), Peer To Peer Network (OTC:PTOP), and Acurx Pharmaceuticals (NASDAQ:ACXP). NEW YORK CITY, NY / AC......
12.11.25 - 15:24
Earnings Call Transkript: Acurx Pharmaceuticals gibt für Q3 2025 verhaltenen Ausblick (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.11.25 - 13:12
Acurx Pharmaceuticals GAAP EPS of -$1.23 beats by $0.05 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.11.25 - 13:07
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update (PR Newswire)
 
STATEN ISLAND, N.Y., Nov. 12, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and......
10.11.25 - 14:03
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens (PR Newswire)
 
DNA polymerase (pol) IIIC inhibitors are an innovative new class of antibiotics, the first in more than 30 years, that target a critical enzyme of Gram-positive bacteria including C. difficile, MRSA, VRE and PRSP (penicillin-resistant Streptococcus pneumonia) Acurx's lead DNA pol IIIC......
27.10.25 - 13:06
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update (PR Newswire)
 
STATEN ISLAND, N.Y., Oct. 27, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company will discuss......
25.10.25 - 19:06
New to The Street to Broadcast Nationwide on Bloomberg TV Tonight at 6:30 PM EST Featuring Roadzen, Spartan Equipment, XION, Metaterra, and YY Group (Accesswire)
 
The show broadcasts as sponsored programming with featured commercials by Laser Photonics (NASDAQ:LASE), PetVivo (OTCQB:PETV), Aeries Technology (NASDAQ:AERT), Acurx Pharmaceuticals (NASDAQ:ACXP), ......
11.10.25 - 19:06
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group (Accesswire)
 
The show is sponsored programming with commercials featuring LASE Technologies ($LASE), PetVivo ($PETV), Acurx Pharmaceuticals ($ACXP), Synergy CHC ($SNYR), and NewsOut - the video press release co......
09.10.25 - 13:33
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors (PR Newswire)
 
STATEN ISLAND, N.Y., Oct. 9, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that a new......
04.10.25 - 19:18
New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST (Accesswire)
 
Sponsored Programming Featuring Commercials by Laser Photonics Corp. (NASDAQ:LASE), Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP), PetVivo Holdings, Inc. (NASDAQ:PETV), DataVault AI (NASDAQ:DVLT), and ......
30.09.25 - 13:33
Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection (PR Newswire)
 
The Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on Acurx's Pediatric Investigation Plan (PIP) for ibezapolstat use in children with C. difficile infection Receipt of this positive opinion caps off the EMA's requirement to have the PIP agreed to......
27.09.25 - 00:06
New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies (Accesswire)
 
Bloomberg Television 6:30 PM ET as Sponsored Programming - With TV Commercials Debuting by Laser Photonics $LASE, Synergy CHC $SNYR, Sustainable Green Team $SGTM, and Acurx Pharmaceuticals $ACXP NE......
06.09.25 - 16:09
Acurx Pharmaceuticals, Inc. Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events (Accesswire)
 
NEW YORK CITY, NY / ACCESS Newswire / September 6, 2025 / New to The Street, one of the nation's premier financial media platforms, today announced that Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP), a......
03.09.25 - 13:45
Acurx Pharmaceuticals regains compliance with Nasdaq’s listing rules (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.08.25 - 19:54
New to The Street T.V. Broadcasting on Bloomberg Saturday Aug 30th. The episode features TON Strategy Company, Laser Photonics, Sullivan & Cromwell Senior M&A Partner Frank Aquila, and Mercurity Fintech (Accesswire)
 
Sponsored TV commercials by NRx Pharma (NASDAQ:NRXP), Synergy CHC (NASDAQ:SNYR), ACURX Pharmaceuticals (NASDAQ:ACXP), and Sustainable Green Team (OTCQX:SGTM). NEW YORK CITY, NEW YORK / ACCESS Newsw......
12.08.25 - 16:21
Acurx signals ongoing cost controls and new trial funding avenues while advancing ibezapolstat clinical program (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.08.25 - 13:12
Acurx Pharmaceuticals GAAP EPS of -$1.89 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.08.25 - 13:03
Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update (PR Newswire)
 
STATEN ISLAND, N.Y., Aug. 12, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and......
05.08.25 - 08:12
XFRA: 3ZO0: Aussetzung/Suspension (XETRA)
 
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL ACURX PHARMACEUT. NEW ON 3ZO0 US00510M2035 BAW/UFN...
05.08.25 - 08:12
XFRA: INSTRUMENT_SUSPENSION - US00510M2035 (XETRA)
 
Instrument ID [24968546] (3ZO0 - US00510M2035) suspended...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer lesen kann, der ist niemals einsam. - Prof. Dr. Walter Jens
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!